# Exploratory Study of ZG-801 for the Treatment of Hyperkalemia

> **NCT03799926** · PHASE2 · COMPLETED · sponsor: **Zeria Pharmaceutical** · enrollment: 184 (actual)

## Conditions studied

- Hyperkalemia

## Interventions

- **DRUG:** patiromer
- **DRUG:** patiromer
- **DRUG:** placebo
- **DRUG:** placebo
- **DRUG:** patiromer
- **DRUG:** patiromer
- **DRUG:** patiromer
- **DRUG:** patiromer

## Key facts

- **NCT ID:** NCT03799926
- **Lead sponsor:** Zeria Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-18
- **Primary completion:** 2019-11-06
- **Final completion:** 2021-02-02
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2021-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03799926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03799926, "Exploratory Study of ZG-801 for the Treatment of Hyperkalemia". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT03799926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*